The US has launched a trade probe into Germany's pharmaceutical pricing, alleging it unfairly burdens American commerce and forces the US t...

Alembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step fo...

As the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...

Americans face growing challenges affording healthcare. New data reveals a significant drop in those able to manage medical costs and acces...

The All India Defence Employees’ Federation (AIDEF) has urged the 8th Pay Commission to replace the AICPI-IW-based inflation measure with a...

Indian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...

The Jan Aushadhi scheme had made medicines up to 60% cheaper and helped families save nearly Rs 40,000 crore across the country, Sitharaman...

India's health sector has seen historic changes in the last 12 years. Accessible, affordable, and quality healthcare is now a reality for c...

European shares surged on Friday, driven by renewed hopes for a Middle East diplomatic breakthrough that lowered oil prices. The pan-Europe...

India's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...

The benchmark snapped a four-day losing streak on Thursday, as ⁠investors digested the European Central Bank's rate hike and largely looked...

India's drug price regulator has increased the ceiling prices of cancer drugs cisplatin and carboplatin by 50% to tackle shortages caused b...

Britain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...

With an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...

India's drug pricing authority has approved a 50% price hike for essential anti-cancer drugs carboplatin and cisplatin. This decision follo...

India's healthcare sector has seen a major transformation over the last 12 years. Health insurance coverage has expanded significantly. Mat...

Cancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues a...